Bayer Articles
Public Citizen’s HRG slams Pfizer’s $2.3 billion settlement as not enough to deter bad behaviour by Pharma
9 September 2009
UK’s NICE again refuses Nexavar for liver cancer patients
8 September 2009
Bayer completes Ph II rivaroxaban study enrollment
1 September 2009
Bayer submits new Levitra formulation in EU
19 August 2009
Novartis Multiple sclerosis drug Extavia cleared by US FDA
17 August 2009
US FDA clears new formulation of Actelion’s Ventavis
10 August 2009
Bionovo names Klaus Kohl CTO
4 June 2009
Stock Commentary - Europe - week to June 1, 2009
4 June 2009
Bayer reports further riociguat data at ATS
3 June 2009
Onyx/Bayer initiate Ph III Nexavar trial
3 June 2009
FDA does not ask for new rivaroxaban trials
3 June 2009
Fresenius licenses HES platform to Bayer
2 June 2009
Japan: no added use for Nexavar, Alimta
27 May 2009
Bayer/Onyx
21 May 2009
US FDA approves Impax' generic Precose
20 May 2009
Onyx asserts right to Ph II drug against Bayer
19 May 2009
246M euros for EC/EFPIA's IMI drug R&D project
19 May 2009
Bayer begins European roll-out of Qlaira
14 May 2009
Xarelto more effective than enoxaparin in VTE
11 May 2009
Evotec buys Sumit Zebrafish operations
8 May 2009
Bayer debuts first TV ad for Levonelle in UK
29 April 2009
NICE's "bizarre" decision
29 April 2009
Bayer licenses Ardea's MEKs for up to $407M
29 April 2009
Bayer hit by charges and falling material science sales in 1st qtr, but pharma division doing well
29 April 2009
Bayer and Onyx halt Nexavar trial
28 April 2009
URCH study foresees more pharma mega-mergers
27 April 2009
Positive HCC data for Y-90 radioembolization
24 April 2009
Novartis' 1st-qtr 2009 results boosted by new products
24 April 2009
Stock Commentary - Europe - week to Aug 15
8 April 2009
Teva gets FDA appro for generic Yaz
3 April 2009
Stock Commentary - Europe - week to mar 30, 2009
2 April 2009
Solvay viewing options for pharma
2 April 2009
Bayer launches DTP scheme in UK
1 April 2009
Afinitor cleared in USA for advanced RCC
1 April 2009
Bayer Yakuhin aiming for $2.06B annual sales
31 March 2009
Stock Commentary - Europe - week to March 23, 2009
30 March 2009
Sutent cleared for UK kidney cancer patients
30 March 2009
Pradaxa Ph III stroke program nears end
30 March 2009
Levitra extends erection time up to three times
30 March 2009
Bayer to launch MS drug in titration pack
27 March 2009
Ferring promotes Paul Korner to SVP of FIPCUS
23 March 2009
Stock Commentary - Europe - week to Mar 16, 2009
23 March 2009
Bayer drops 10% ahead of rivaroxaban review
23 March 2009
New guidelines for blood cancer therapy
23 March 2009
GW soars 51% on positive data from 3rd Ph III Sativex study; EU submission set for 2nd qtr
23 March 2009
Bayer Technology Services opens office in India
16 March 2009
Shire launches Fosrenol in Japan
16 March 2009
NICE gives nod to Bayer's Xarelto
16 March 2009
Bayer Schering Pharma named and shamed over UK Code
9 March 2009
Nexavar pushes Onyx back to profit
9 March 2009
Stock Commentary - Europe - week to Feb 23, 2009
2 March 2009
Bayer cleared to begin UK trials of riociguat
23 February 2009
Drugmakers remain attractive employers in Belgium
23 February 2009
Bayer must retract television adverts for Yaz to settle law suit
16 February 2009
Bayer to establish R&D facility in Beijing
16 February 2009
Bayer takes riociguat into Phase III
16 February 2009
ED drugmakers accused of price-fixing in Switzerland
16 February 2009
Affimed gets 550K euro grant from MITI initiative
16 February 2009
Sutent available in England, not Scotland
9 February 2009
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
Stock Commentary - Europe - week to Jan 19, 2009
26 January 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Cumberland names Barry Lee as product director
19 January 2009
Stock Commentary - Europe - week to Jan 19, 2009
19 January 2009
Bayer pays Micromet $6M for option on Ab
19 January 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Bayer signs PET deal with Hamamatsu
12 January 2009
Stock Commentary - Europe - week to Jan 5, 2009
12 January 2009
Bayer's Visanne submitted for EU approval
12 January 2009
Bayer sues Abbott for slice of Humira earnings
12 January 2009
Bayer updates press on current pipeline
12 January 2009
Stock Commentary - Europe - week to Dec 15, 2008
22 December 2008
Bayer chairman calls for R&D tax breaks
22 December 2008
Free morning-after pill for UK
22 December 2008
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
